Skip to Main Content

Paper Details

Translational in vitro and in vivo PKPD modelling for apramycin against Gram-negative lung pathogens to facilitate prediction of human efficacious dose in pneumonia.
Clin Microbiol Infect
6
2022
Author NameAffiliation
Johan LindbergRISE Research Institutes of Sweden
  • 1 - 1

Datasets

Release 1.2